Cargando…
Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials
More than 150 million people worldwide are chronically infected with hepatitis C virus (HCV) and face higher risk of cirrhosis and hepatocellular carcinoma. Highly effective HCV treatments have recently been developed; however, they are costly and therefore poorly suited for application in resource-...
Autores principales: | Loftfield, Erikka, O’Brien, Thomas R., Pfeiffer, Ruth M., Howell, Charles D., Horst, Ron, Prokunina-Olsson, Ludmila, Weinstein, Stephanie J., Albanes, Demetrius, Morgan, Timothy R., Freedman, Neal D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104464/ https://www.ncbi.nlm.nih.gov/pubmed/27832143 http://dx.doi.org/10.1371/journal.pone.0166036 |
Ejemplares similares
-
A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer
por: Farhat, Zeinab, et al.
Publicado: (2022) -
Coffee and digestive cancers—what do we know, and where do we go?
por: Loftfield, Erikka, et al.
Publicado: (2020) -
What makes the hepatitis C virus evolve?
por: O'Brien, Thomas R, et al.
Publicado: (2019) -
Physical activity across the lifespan and liver cancer incidence in the NIH‐AARP Diet and Health Study cohort
por: Arem, Hannah, et al.
Publicado: (2018) -
A Metabolomic Study of the Variability of the Chemical Composition of Commonly Consumed Coffee Brews
por: Rothwell, Joseph A., et al.
Publicado: (2019)